PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
Clinical trial NCT02732171 · RECRUITING
Trial details
- NCT number
- NCT02732171
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2028-04-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.